Skip to main content
HR 1840 115th Congress House Taxation Drug safety, medical device, and laboratory regulation Health technology, devices, supplies Income tax credits Infectious and parasitic diseases Medical tests and diagnostic methods

Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017

Introduced: March 30, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 30, 2017
Referred to the House Committee on Ways and Means.
Mar 30, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017

This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection.

What's happening now March 30, 2017

Referred to the House Committee on Ways and Means.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 5
All 5 Democratic 1 Republican 1
Lance, Leonard
· Sep 5, 2017
 R
DesJarlais, Scott
Tennessee · Jul 14, 2017
SHIMKUS, JOHN
· Mar 30, 2017
 D
Thompson, Mike
California · Mar 30, 2017
Walz, Timothy
· Mar 30, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1840/
MLA
"H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1840/.
Bluebook (legal)
H.R. 1840, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1840/.
Markdown link
[H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017](https://openamerica.io/bill/115-HR-1840/)
Report a problem